References
- VAKITI A., MEWAWALLA P. Acute Myeloid Leukemia. StatPearls [Internet]. 2021 Aug 17 [cited 2022 Jul 12]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK507875/
- DӦHNER H., WEI A.H., APPELBAUM F.R., CRADDOCK C., DINARDO C.D., DOMBRET H., et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–77.
- KHOURY J.D., SOLARY E., ABLA O., AKKARI Y., ALAGGIO R., APPERLEY J.F., et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703-1719.
- RACK K.A., VAN DEN BERG E., HAFERLACH C., BEVERLOO H.B., COSTA D., ESPINET B., et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia. 2020;34(8):2262.
- YAHYA D., HACHMERIYAN M., MICHEVA I., CHERVENKOV T. Acute myelogenous leukemia – current recommendations and approaches in molecular-genetic assessment. Romanian Journal of Internal Medicine. 2022;60(2):103–14.
- ALONSO C.M., LLOP M., SARGAS C., PEDROLA L., PANADERO J., HERVÁS D., et al. Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics. Journal of Molecular Diagnostics. 2019;21(2):228–40.
- IBÁÑEZ M., SUCH E., ONECHA E., GOMEZ-SEGUI I., LIQUORI A., SELLES J., et al. Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype. Scientific Reports. 2020;10(1):1–12.
- BERRY N.K., SCOTT R.J., ROWLINGS P., ENJETI A.K. Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies. Crit Rev Oncol Hematol. 2019;142:58–67.
- LEISCH M., JANSKO B., ZABORSKY N., GREIL R., PLEYER L. Next Generation Sequencing in AML–On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation? Cancers (Basel). 2019;11(2):252.
- HӦMIG-HӦLZEL C., SAVOLA S. Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol. 2012;21(4):189–206.
- PAYNE A.B., BEAN C.J., HOOPER W.C., MILLER C.H. Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening. J Thromb Haemost. 2012;10(9):1951–4.
- ALPÁR D., DE JONG D., SAVOLA S., YIGITTOP H.A., KAJTÁR B., KERESKAI L., et al. MLPA is a powerful tool for detecting lymphoblastic transformation in chronic myeloid leukemia and revealing the clonal origin of relapse in pediatric acute lymphoblastic leukemia. Cancer Genet. 2012;205(9):465–9.
- KOSZTOLANYI S., KISS R., ATANESYAN L., GÁNGO A., de Groot K, Steenkamer M, et al. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma. The Journal of Molecular Diagnostics. 2018;20(6):777–88.
- AHN J.W., MACKIE O.C., WELCH A., THOMAS H., MADULA R., HILLS A., et al. Detection of subtelomere imbalance using MLPA: Validation, development of an analysis protocol, and application in a diagnostic centre. BMC Med Genet. 2007;8(1):1–13.
- STUPPIA L., ANTONUCCI I., PALKA G., GATTA V. Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases. Int J Mol Sci. 2012;13(3):3245–76.
- BALGOBIND B.V., HOLLINK I.H.I.M., REINHARDT D., VAN WERING E.R., DE GRAAF S.S.N., BARUCHEL A., et al. Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique. Eur J Cancer. 2010 Jul;46(10):1892–9.
- YU C.H., LIN T.K., JOU S.T., LIN C.Y., LIN K.H., LU M.Y., et al. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia. Scientific Reports. 2020;10(1):1–11.
- DONAHUE A.C., ABDOOL A.K., GAUR R., WOHLGEMUTH J.G., YEH C.H. Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia. Leuk Res. 2011;35(11):1477–83.
- BANESKU C., TRIPON F., TRIFA A.P., CRAUCIUC A.G., BOGLIS A., LAZAR E., et al. Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Pol Arch Intern Med. 2019; 129(12):898-906
- SHIMONY S., STAHL M., STONE R.M. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(3):502–26.
- TRIPON F., CRAUCIUC A.G., MOLDOVAN V.G., BOGLIS A., BENEDEK I., LAZAR E., et al. Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study. Rev Rom Med Lab. 2019;27(3):245–54.
- BANESKU C., TRIPON F., TRIFA A.P., CRAUCIUC A.G., BOGLIS A., LAZAR E., et al. Presence of copy number aberrations and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Authors’ reply. Pol Arch Intern Med. 2020;130(4):347–8.